Umaharan T, Sivayokan S, Sivansuthan S
Senior Registrar in Psychiatry Teaching Hospital, Jaffna, Sri Lanka.
Consultant Psychiatrist, Teaching Hospital, Jaffna, Sri Lanka.
Case Rep Psychiatry. 2021 Jan 29;2021:6647952. doi: 10.1155/2021/6647952. eCollection 2021.
Amitriptyline, the second antidepressant invented next to imipramine, is indicated in many psychiatric conditions as well as for some organic disorders. The drug acts by increasing the availability of monoamines in the central nervous system postsynaptic clefts. Amitriptyline has long been suspected for abusive potential based on a few case reports, and the reports add evidence in favor of the hypothesis. This case report brings such material to the arena of evidence and discusses the probable mechanisms by which patients turn to abusing and be addicted to the drug. The article also argues matters associated with drug dispensing that might raise the risk of misuse of the drug, especially in countries where strict legislation for accessibility of prescribed drugs is not in practice.
阿米替林是继丙咪嗪之后发明的第二种抗抑郁药,适用于多种精神疾病以及一些器质性疾病。该药物通过增加中枢神经系统突触后间隙中单胺类神经递质的可用性来发挥作用。长期以来,基于一些病例报告,人们一直怀疑阿米替林存在滥用可能性,这些报告为这一假说提供了支持证据。本病例报告将此类资料引入证据领域,并探讨了患者滥用和成瘾该药物的可能机制。文章还讨论了与药物配给相关的问题,这些问题可能会增加药物滥用的风险,尤其是在那些没有实施严格处方药获取立法的国家。